…
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Americann Inc is an OTC Pink–listed microcap whose public filings report activities in the cannabis/hemp sector. Long-term growth drivers could include broader legalization, rising consumer demand for regulated products and operational scale if licensing and capital are secured; the company may appeal to investors seeking exposure to emerging cannabis markets contingent on improved transparency and execution.
Primary risks are limited and irregular public disclosure, thin trading liquidity, regulatory and licensing uncertainty in cannabis markets and significant execution and financing risk for small OTC issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Income before tax | -1.25M | -0.09M | -0.17M | -0.86M | -0.71M |
| Net income | -1.25M | -0.09M | -0.83M | -1.79M | -1.57M |
| Selling general administrative | 2.01M | 1.91M | 2.36M | 1.90M | 2.41M |
| Selling and marketing expenses | 0.01M | 0.01M | 0.04M | 0.04M | 0.04M |
| Gross profit | 1.27M | 2.54M | 2.88M | 1.99M | 0.48M |
| Reconciled depreciation | 0.53M | 0.53M | 0.52M | 0.52M | 0.51M |
| Ebit | -0.70M | 0.62M | 0.49M | 0.06M | 0.15M |
| Ebitda | -0.17M | 1.14M | 1.01M | 0.58M | 0.66M |
| Depreciation and amortization | 0.53M | 0.53M | 0.52M | 0.52M | 0.51M |
| Operating income | -0.75M | 0.61M | 0.48M | 0.06M | 0.15M |
| Other operating expenses | 2.02M | 1.94M | 2.45M | 1.98M | 0.69M |
| Interest expense | 0.55M | 0.71M | 0.67M | 0.93M | 0.86M |
| Interest income | 0.04M | 0.00M | 0.01M | 0.02M | 0.33M |
| Net interest income | -0.51M | -0.71M | -0.66M | -0.91M | -0.52M |
| Income tax expense | - | 0.00M | 0.66M | 0.93M | 0.86M |
| Total revenue | 1.27M | 2.55M | 2.93M | 2.03M | 0.50M |
| Total operating expenses | 2.02M | 1.92M | 2.40M | 1.95M | 0.69M |
| Cost of revenue | 0.00M | 0.02M | 0.05M | 0.04M | 0.02M |
| Total other income expense net | -0.51M | -0.71M | -0.66M | -0.91M | -0.52M |
| Net income from continuing ops | -1.25M | -0.09M | -0.17M | -0.86M | -0.71M |
| Net income applicable to common shares | - | - | -0.17M | -0.86M | -0.71M |
| Breakdown | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Total assets | 14.06M | 15.15M | 15.44M | 15.06M | 14.87M |
| Other current assets | 0.14M | 0.02M | 0.01M | 0.01M | 0.01M |
| Total liab | 9.61M | 9.45M | 9.64M | 9.55M | 8.99M |
| Total stockholder equity | 4.45M | 5.71M | 5.80M | 5.51M | 5.87M |
| Other current liab | 0.18M | - | 0.01M | 0.01M | 0.02M |
| Common stock | 0.00M | - | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -21.11M | -19.85M | -19.76M | -19.59M | -18.72M |
| Other assets | - | - | - | 0.04M | 0.08M |
| Cash | 0.05M | 1.14M | 1.34M | 0.70M | 0.18M |
| Total current liabilities | 5.42M | 5.24M | 0.50M | 0.51M | 0.59M |
| Net debt | 9.24M | 3.95M | 3.73M | 4.27M | 4.13M |
| Short term debt | 5.09M | - | - | - | - |
| Short long term debt | 5.08M | 5.08M | 0.15M | 0.15M | 0.15M |
| Short long term debt total | 9.29M | - | - | - | - |
| Other stockholder equity | 25.56M | - | - | - | - |
| Property plant equipment | - | - | 13.73M | 14.00M | 14.43M |
| Total current assets | 0.42M | 1.33M | 1.71M | 1.02M | 0.36M |
| Net tangible assets | - | - | 5.80M | 5.51M | 5.87M |
| Net receivables | 0.23M | 0.10M | 0.29M | 0.30M | 0.16M |
| Long term debt | - | - | 4.92M | 4.81M | 4.16M |
| Accounts payable | 0.14M | 0.10M | 0.19M | 0.19M | 0.28M |
| Non currrent assets other | 0.37M | - | - | - | - |
| Non current assets total | 13.65M | 13.82M | 13.73M | 14.04M | 14.51M |
| Capital lease obligations | 4.20M | 4.22M | 4.23M | 4.24M | 4.25M |
| Breakdown | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Investments | 0.08M | -0.64M | -0.20M | -0.06M | -0.36M |
| Change to liabilities | - | - | -0.01M | -0.05M | 0.08M |
| Total cashflows from investing activities | 0.08M | - | -0.20M | -0.06M | -0.36M |
| Net borrowings | 0.00M | - | - | 0.35M | -1.26M |
| Total cash from financing activities | 0.00M | -0.15M | -0.30M | 0.85M | -1.26M |
| Change to operating activities | - | - | -0.06M | -0.18M | 1.62M |
| Net income | -1.25M | -0.09M | -0.17M | -0.86M | -0.71M |
| Change in cash | -1.09M | -0.21M | 0.64M | 0.51M | -1.10M |
| Begin period cash flow | 1.14M | 1.35M | 0.71M | 0.19M | 1.29M |
| End period cash flow | 0.06M | 1.14M | 1.35M | 0.71M | 0.19M |
| Total cash from operating activities | -1.17M | 0.58M | 0.85M | -0.28M | 0.52M |
| Issuance of capital stock | - | - | - | - | 0.15M |
| Depreciation | 0.53M | 0.53M | 0.52M | 0.52M | 0.51M |
| Other cashflows from investing activities | 0.08M | - | 0.04M | 0.03M | 0.03M |
| Change to inventory | - | -0.09M | - | - | 0.03M |
| Change to account receivables | -0.51M | 0.15M | 0.01M | -0.13M | -0.11M |
| Other cashflows from financing activities | - | -0.64M | -0.20M | 0.50M | -0.36M |
| Change to netincome | - | - | 0.46M | 0.46M | -1.29M |
| Capital expenditures | 0.00M | 0.28M | 0.25M | 0.09M | 0.39M |
| Change in working capital | -0.45M | -0.01M | -0.07M | -0.24M | 1.69M |
| Stock based compensation | - | 0.00M | 0.37M | 0.37M | 0.38M |
| Other non cash items | -0.45M | 0.16M | 0.20M | 0.30M | 0.40M |
| Free cash flow | -1.17M | 0.30M | 0.60M | -0.37M | 0.13M |
Sector: Real Estate Industry: Real Estate Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ACAN Americann Inc |
- -% |
0.00 | - | - | 0.00 | 0.00 | 8.33 | 67.37 |
| CBRE CBRE Group Inc Class A |
-1.55 1.21% |
126.77 | 38.92 | 21.37 | 1.09 | 4.95 | 1.28 | 25.73 |
| BEKE Ke Holdings Inc |
0.07 0.39% |
17.87 | 42.90 | 16.92 | 0.33 | 2.33 | 1.66 | 24.07 |
| VNNVF Vonovia SE |
-0.34 1.81% |
18.20 | - | 13.44 | 3.96 | 0.83 | 4.07 | -3.05 |
| VTAGY Vantage Towers AG |
- -% |
21.42 | 42.00 | 37.59 | 28.32 | 3.61 | 21.19 | 24.26 |
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.
| Name | Title | Year Born |
|---|---|---|
| Mr. Timothy Ryan Keogh | CEO, Pres & Director | 1980 |
| Mr. Benjamin J. Barton | Founder, Chief Financial & Accounting Officer and Director | 1965 |
| Dr. Rien Havens Ph.D. | Extraction & Infused Product Advisor and Member of Advisory Board | NA |
| Mr. Eric Forington | Genetics & Breeding Advisor and Member of Advisory Board | NA |
| Dr. D. Michael Anderson | Medical Advisor & Member of Advisory Board | NA |
| Mr. Nick Brait | Licensing & Compliance Advisor and Member of Advisory Board | NA |
| Mr. Timothy Ryan Keogh | CEO, President & Director | 1980 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.